Kisspeptin-10 (10mg)

Additional Info

Properties

• Chemical Formula: C63H83N17O14
• Molecular Weight: 1302.4 g/mol
• Sequence: YNWNSFGLRF
• Total Amount of the Active Ingredient: 10mg (1 vial)
• Shelf Life: 36 months

Shipping

Available to USA and Canada. For international orders, if your shipment is seized, contact us for a 50% discount applicable on your next purchase.

Disclaimer

The information provided is not a substitute for medical advice, diagnosis, or treatment. Consult your physician or qualified healthcare provider for any medical concerns. Never delay seeking medical advice based on information seen or read here. We assume no responsibility or liability for the use of our research compounds and products, which are sold exclusively for research purposes. They are not intended for personal use.

Additional Label & Product Information

Essential Warning:

The chemicals are intended solely for research or laboratory use and are not approved by the FDA for human consumption.

Usage Instructions:

Avoid skin and eye contact. If contact occurs, rinse thoroughly with water. Seek medical assistance if feeling unwell or in case of accidental ingestion. Store the lyophilized (freeze-dried) peptide at room temperature immediately upon receipt and avoid frequent freeze-thaw cycles to maintain peptide stability.

Product Disclaimer:

This product is not meant to diagnose, treat, cure, or prevent any disease. Administer only as specified by your specific research or laboratory protocol.

Resources

1. Jayasena CN, Nijher GM, Comninos AN, Abbara A, Januszewki A, Vaal ML, Sriskandarajah L, Murphy KG, Farzad Z, Ghatei MA, Bloom SR, Dhillo WS. Kisspeptin-10’s effects on reproductive hormone release exhibit sexual dimorphism in humans. J Clin Endocrinol Metab. 2011 Dec;96(12):E1963-72. doi: 10.1210/jc.2011-1408. PMID: 21976724; PMCID: PMC3232613.
2. George JT, Veldhuis JD, Roseweir AK, Newton CL, Faccenda E, Millar RP, Anderson RA. Kisspeptin-10 strongly stimulates LH secretion and increases pulse frequency in men. J Clin Endocrinol Metab. 2011 Aug;96(8):E1228-36. doi: 10.1210/jc.2011-0089. PMID: 21632807; PMCID: PMC3380939.
3. Navarro VM. Metabolic control of kisspeptin: linking energy balance with reproduction. Nat Rev Endocrinol. 2020 Aug;16(8):407-420. doi: 10.1038/s41574-020-0363-7. PMID: 32427949; PMCID: PMC8852368.
4. Pazarci P, Kaplan H, Alptekin D, Yilmaz M, Lüleyap U, Singirik E, Pelit A, Kasap H, Yegani A. Daylight exposure effects on melatonin levels, Kiss1 expression, and melanoma in mice. Croat Med J. 2020 Feb 29;61(1):55-61. doi: 10.3325/cmj.2020.61.55. PMID: 32118379; PMCID: PMC7063558.
5. Comninos AN, Wall MB, Demetriou L, Shah AJ, Clarke SA, Narayanaswamy S, Nesbitt A, Izzi-Engbeaya C, Prague JK, Abbara A, Ratnasabapathy R, Salem V, Nijher GM, Jayasena CN, Tanner M, Bassett P, Mehta A, Rabiner EA, Hönigsperger C, Silva MR, Brandtzaeg OK, Lundanes E, Wilson SR, Brown RC, Thomas SA, Bloom SR, Dhillo WS. Kisspeptin alters sexual and emotional brain processing in humans. J Clin Invest. 2017 Feb 1;127(2):709-719. doi: 10.1172/JCI89519. PMID: 28112678; PMCID: PMC5272173.
6. Shoji I, Hirose T, Mori N, Hiraishi K, Kato I, Shibasaki A, Yamamoto H, Ohba K, Kaneko K, Morimoto R, Satoh F, Kohzuki M, Totsune K, Takahashi K. Expression of kisspeptins and kisspeptin receptor in the kidney of chronic renal failure rats. Peptides. 2010 Oct;31(10):1920-5. doi: 10.1016/j.peptides.2010.07.001. PMID: 20621140.
7. Sato K, Shirai R, Hontani M, Shinooka R, Hasegawa A, Kichise T, Yamashita T, Yoshizawa H, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T. Potent vasoconstrictor kisspeptin-10 induces atherosclerotic plaque progression and instability, reversible by GPR54 antagonist. J Am Heart Assoc. 2017 Apr 14;6(4):e005790. doi: 10.1161/JAHA.117.005790. PMID: 28411243; PMCID: PMC5533042.